Athenex's IPO

Athenex raised a round of funding on June 14, 2017. Investors include Public.

Athenex (NASDAQ: ATNX), formerly Kinex Pharmaceuticals, is a global oncology pharmaceutical company focused on the development and commercialization of next generation therapies for cancer diseases an…

Articles about Athenex's IPO: